摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-methyl-1-(2-oxo-2-((2R,3R,4R,5R)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl)ethyl)guanidine | 1198162-84-3

中文名称
——
中文别名
——
英文名称
1-methyl-1-(2-oxo-2-((2R,3R,4R,5R)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl)ethyl)guanidine
英文别名
1-methyl-1-[2-oxo-2-[(2R,3R,4R,5R)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]ethyl]guanidine
1-methyl-1-(2-oxo-2-((2R,3R,4R,5R)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl)ethyl)guanidine化学式
CAS
1198162-84-3
化学式
C10H20N4O5
mdl
——
分子量
276.293
InChiKey
RHGNTNUPCZGLCU-SQEXRHODSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3.4
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    154
  • 氢给体数:
    6
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    1-methyl-1-(2-oxo-2-((2R,3R,4R,5R)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl)ethyl)guanidine柠檬酸异丙醇 为溶剂, 生成 tris(1-methyl-1-(2-oxo-2-((2R,3R,4R,5R)-3,4,5-trihydroxy-2-(hydroxy-methyl)piperidin-1-yl)ethyl)guanidine) 2-hydroxypropane-1,2,3-tricarboxylate
    参考文献:
    名称:
    Salts of creatine imino sugar amides
    摘要:
    本发明涉及肌酸亚胺糖酰胺的稳定盐和一种无机或有机酸,具有增强的营养和/或治疗功效,相对于它们各自的效应,并且包含这些盐的固体组合物,特别适用于口服和静脉注射。还提供了这些组合物的制备和使用方法。
    公开号:
    US20090298877A1
点击查看最新优质反应信息

文献信息

  • Preparations containing creatine and imino sugars
    申请人:Heuer Marvin A.
    公开号:US20090297685A1
    公开(公告)日:2009-12-03
    Compounds produced by combining imino sugars and creatine are herein disclosed. The compounds being in the form of a creatine imino sugar amides and produced by the disclosed methods; protecting the guanidine group of creatine and then activating the protected creatine with DCC and reacting it with an imino sugar, followed by removal of the guanidine protecting groups. The resulting creatine imino sugar amides have enhanced stability in solution as compared to related esters. In addition, specific benefits are conferred by the imino sugar in addition to, and separate from, the creatine substituent. Methods of preparation and use of these compounds are also disclosed.
    本文公开了通过合并亚胺糖和肌酸而产生的化合物。该化合物以肌酸亚胺糖酰胺的形式存在,并通过所公开的方法制备;先保护肌酸的胍基团,然后用DCC激活保护的肌酸并与亚胺糖反应,随后去除胍基保护基团。与相关酯相比,所得到的肌酸亚胺糖酰胺在溶液中具有增强的稳定性。此外,亚胺糖还赋予特定的益处,除了与肌酸取代基分离外。本文还公开了这些化合物的制备和使用方法。
  • US8426395B2
    申请人:——
    公开号:US8426395B2
    公开(公告)日:2013-04-23
  • US8546369B2
    申请人:——
    公开号:US8546369B2
    公开(公告)日:2013-10-01
  • [EN] CREATINE SUGAR AMIDES AND SALTS THEREOF<br/>[FR] AMIDES DE CRÉATINE ET DE SUCRES ET SELS DE CEUX-CI
    申请人:NORTHERN INNOVATIONS AND FORMU
    公开号:WO2009143630A1
    公开(公告)日:2009-12-03
    Compounds produced by combining imino sugars and creatine and salts thereof are herein disclosed. The compounds being in the form of creatine imino sugar amides and the salts being combinations of various creatine imino sugar amides with an inorganic or organic acid. The resulting creatine imino sugar amides have enhanced stability in solution as compared to related esters and the resulting salts are particularly well suited for oral and parenteral use. In addition, specific benefits are conferred by the imino sugar in addition to, and separate from, the creatine substituent. Methods of preparation and use of these compounds are also disclosed.
  • Salts of creatine imino sugar amides
    申请人:Heuer Marvin A.
    公开号:US20090298877A1
    公开(公告)日:2009-12-03
    The present invention relates to stable salts of creatine imino sugar amides and an inorganic or organic acid endowed with enhanced nutritional and/or therapeutical efficacy in respect to their individual effects and to solid compositions containing such salts, particularly suited to oral and parenteral administration. Methods of preparation and use of these compositions are also provided.
    本发明涉及肌酸亚胺糖酰胺的稳定盐和一种无机或有机酸,具有增强的营养和/或治疗功效,相对于它们各自的效应,并且包含这些盐的固体组合物,特别适用于口服和静脉注射。还提供了这些组合物的制备和使用方法。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物